Eµ-TCL1小鼠CLL纵向分析揭示白血病相关克隆变化及Myc增益预测患者不良预后
该研究对Eµ-TCL1小鼠的纵向白血病样本进行全外显子和B细胞受体测序,发现白血病多为单克隆,存在B细胞受体刻板性及与CLL相关的克隆突变和15号染色体(含Myc)反复增益。人类8q24(含MYC)扩增与CLL患者更差预后相关,提示该小鼠模型适用于进展性CLL研究。
要点
- Eµ-TCL1小鼠白血病多为单克隆,罕见寡克隆与过继转移后不能致病相关。
- 鉴定出与CLL相关的克隆突变序贯获得及15号染色体(含Myc)反复增益。
- 人类8q24(含MYC)扩增与CLL患者更差预后相关。
核心结论
- Eµ-TCL1小鼠CLL模型再现了患者中的B细胞受体刻板性和克隆演化,支持其用于进展性CLL研究。
- 小鼠15号染色体(含Myc)反复增益对应人类8q24(含MYC)扩增,后者与CLL患者更差预后相关。
研究设计与样本
- 对Eµ-TCL1小鼠纵向白血病样本进行全外显子组和B细胞受体测序。
- 研究对象为老龄Eµ-TCL1小鼠的CLL样疾病样本。
主要发现
- 观察到B细胞受体刻板性,支持CLL为抗原驱动疾病。
- 深测序显示Eµ-TCL1小鼠白血病主要为单克隆。
- 罕见寡克隆与肿瘤过继转移后不能致病相关。
- 鉴定出克隆变化及与CLL相关突变的序贯获得。
- 几乎全部Eµ-TCL1小鼠肿瘤中反复出现15号染色体(含Myc)增益。
临床怎么用
- Eµ-TCL1小鼠可作为研究CLL克隆演化及进展的临床前模型。
- MYC/8q24扩增状态或可作为CLL患者预后评估的参考指标。
局限性
- 研究基于小鼠模型,人类CLL的遗传复杂性可能未被完全反映。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy mainly occurring at an advanced age with no single major genetic driver. Transgenic expression of TCL1 in B cells leads after a long latency to a CLL-like disease in aged Eµ-TCL1 mice suggesting that TCL1 overexpression is not sufficient for full leukemic transformation. In search for secondary genetic events and to elucidate the clonal evolution of CLL, we performed whole exome and B-cell receptor sequencing of longitudinal leukemia samples of Eµ-TCL1 mice. We observed a B-cell receptor stereotypy, as described in patients, confirming that CLL is an antigen-driven disease. Deep sequencing showed that leukemia in Eµ-TCL1 mice is mostly monoclonal. Rare oligoclonality was associated with inability of tumors to develop disease upon adoptive transfer in mice. In addition, we identified clonal changes and a sequential acquisition of mutations with known relevance in CLL, which highlights the genetic similarities and therefore, suitability of the Eµ-TCL1 mouse model for progressive CLL. Among them, a recurrent gain of chromosome 15, where Myc is located, was identified in almost all tumors in Eµ-TCL1 mice. Interestingly, amplification of 8q24, the chromosomal region containing MYC in humans, was associated with worse outcome of patients with CLL.
引用
- Öztürk S, Paul Y, Afzal S, et al. Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients. Leukemia. 2021. PMID: 34417556. doi:10.1038/s41375-021-01381-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。